• Home
  • About
  • Contact
  • Steve Walker
  • Subscriptions
    • Sample MondayMorning Newsletter January 11, 2016
Monday Morning
Skip to content
  • Home
  • About
  • Contact
  • Steve Walker
  • Subscriptions
    • Sample MondayMorning Newsletter January 11, 2016

Tag Archives: Portola Pharmaceuticals Inc.

GOP Senate bill ignites massive rally in healthcare stocks; remember the dot-com era?

Steve Walker    June 28, 2017 May 7, 2018    No Comments on GOP Senate bill ignites massive rally in healthcare stocks; remember the dot-com era?

US healthcare stocks posted sharp gains last week, with pharma, hospitals and insurers climbing after Senate Republicans released a draft bill to scrap Obamacare, while a recent explosion in biotech… Read more »

Government, Obamacare, Trumpcare    Aetna Inc., Ana Gupte, Anthony Mirhaydari, Betrixaban, Better Care Reconciliation Act, BevyxXa, Bloomberg, Bloomberg Intelligence, Cabometyx, Cara Ther­a­peu­tics Inc., Centene Corp., Congressional Budget Office, Elizabeth Gurdus, Exelixis Inc., HCA Healthcare Inc., ImmunoGen Inc., IV CR845, Jeff Jonas, Jim Cramer, Max Nisen, Medicaid, Molina Healthcare Inc., Obamacare, Portola Pharmaceuticals Inc., President Obama, President Trump, Sheryl Skolnick, Tenet Healthcare Corp., The Financial Times, UnitedHealth Group Inc.

Search The Site

Follow @MonMorningNews

Twitter

Tweets by MonMorningNews
Follow me on Blogarama

Facebook

Search The Site

More MondayMorning

  • Recent Posts
  • Most Commented
  • Most Viewed
  • US stock market has a subdued Thanksgiving week, but a slew of healthcare companies rocketed higher.
  • More Chinese medical companies choosing New York over Shanghai, Hong Kong for IPOs; but not always.
  • Health-sector IPO market cools off for Veterans Day breather; but pre-Thanksgiving deals ready to rock.
  • Health-sector IPO market cools off this week after torrid start to November.
    • Insys trial opens with tale of sales rep giving lap dance to doctor for fentanyl prescriptions. News organizations seize upon...
    • Voyager Therapeutics signs another neurodegenerative disease deal with AbbVie that screams “Buy this small cap now.”
    • Little known Czech biotech’s cell therapy greatly increases survival in ovarian cancer. Sotio’s potential breakthrough and another pipeline cancer candidate...
    • It’s time to reclassify schizophrenia as a neurologic disorder.
    Copyright 2018
    Ribosome by GalussoThemes.com
    Powered by WordPress